Concepedia

Publication | Open Access

Evaluation of cardiovascular events in patients with hepatocellular carcinoma treated with sorafenib in the clinical practice. The CARDIO‐SOR study

DOIFull Paper Access

24

Citations

38

References

2021

Year

Lorena Carballo‐Folgoso, Rut Álvarez‐Velasco, Rebeca Lorca, Andrés Castaño‐García, Javier Cuevas, M.L. González-Diéguez, Carmen Álvarez‐Navascués, Valle Cadahía, Manuel Rodríguez, Marı́a Varela
Liver International

Abstract

The incidence of cardiovascular events in HCC patients treated with SOR is higher than expected. Multidisciplinary approach and clinical tools like CARDIOSOR scale could be helpful to manage these patients.

References

YearCitations

Page 1